Reuters logo
BRIEF-Biothera Pharmaceuticals Enters Cancer Immunotherapy Clinical Trial Collaboration Agreement
November 28, 2017 / 2:21 PM / 16 days ago

BRIEF-Biothera Pharmaceuticals Enters Cancer Immunotherapy Clinical Trial Collaboration Agreement

Nov 28 (Reuters) - Roche Holding Ag:

* BIOTHERA PHARMACEUTICALS ENTERS CANCER IMMUNOTHERAPY CLINICAL TRIAL COLLABORATION AGREEMENT

* ‍BIOTHERA PHARMACEUTICALS - ENTERED INTO CLINICAL TRIAL COLLABORATION AGREEMENT WITH GENENTECH INC ​

* ‍BIOTHERA PHARMACEUTICALS - AGREEMENT TO ASSESS SAFETY AND EFFICACY OF CO‘S IMPRIME PGG IN COMBINATION WITH GENENTECH‘S ATEZOLIZUMAB & BEVACIZUMAB

* ‍BIOTHERA PHARMACEUTICALS - GENENTECH WILL CONDUCT MULTICENTER, WHICH WILL ENROLL APPROXIMATELY 40 PATIENTS IN INITIAL PHASE OF STUDY​

* BIOTHERA PHARMACEUTICALS - COLLABORATION INCLUDES TESTING EXPERIMENTAL COMBINATION IN MORPHEUS, ROCHE‘S CANCER IMMUNOTHERAPY DEVELOPMENT PLATFORM​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below